Industry Leaderboard Gains And Dips Were Still Marked By COVID-19

Pfizer held the number one spot on the Scrip 100 on the strength of its COVID-19 products, while some others faced challenging financial comparisons in 2022 because of COVID-19 headwinds.

Covid trends
• Source: Shutterstock

Pfizer Inc. dominated the Scrip 100 rankings of the top pharmaceutical companies in the world based on full year 2022 pharmaceutical revenues, driven by its COVID-19 success, but Merck & Co., AstraZeneca and Novo Nordisk each rose on the leaderboard, powered more generally by business fundamentals.

It remained an atypical year for the pharmaceutical industry as some big pharma companies continued to generate unusual growth in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from 2024

More from Outlook